Trial intelligence / Profile preview

Effect of Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults

NCT03372733Phase 2Completed

Sponsor
National Heart, Lung, and Blood Institute
Start
Jul 2018
Primary completion
Mar 2026
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in hypercholesterolemia (2 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Low-Density Lipoprotein Cholesterol at 24 weeks. Started Jul 2018; status: completed.

02

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT03372733.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03372733.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call